The Fellow on Call: The Heme/Onc Podcast cover image

Episode 126: AML Series, Pt 12 - Treatment of patients with relapsed/refractory disease

The Fellow on Call: The Heme/Onc Podcast

00:00

Innovative Strategies in AML Treatment

This chapter explores treatment options for patients with relapsed/refractory acute myeloid leukemia (AML), focusing on regimens like FLAG and CLAG that enhance cytarabine's effectiveness. It also addresses the role of novel combinations, such as venetoclax, in improving outcomes for high-risk AML patients amid a lack of comprehensive randomized studies.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app